Michael Holland

1.2k total citations
49 papers, 785 citations indexed

About

Michael Holland is a scholar working on Hematology, Emergency Medicine and Pharmacology. According to data from OpenAlex, Michael Holland has authored 49 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 7 papers in Emergency Medicine and 6 papers in Pharmacology. Recurrent topics in Michael Holland's work include Hemophilia Treatment and Research (23 papers), Poisoning and overdose treatments (7 papers) and CAR-T cell therapy research (5 papers). Michael Holland is often cited by papers focused on Hemophilia Treatment and Research (23 papers), Poisoning and overdose treatments (7 papers) and CAR-T cell therapy research (5 papers). Michael Holland collaborates with scholars based in United Kingdom, United States and Germany. Michael Holland's co-authors include Kate Khair, Jeanna M. Marraffa, Michael Hodgman, Debra Pollard, Simon Fletcher, Ross Sullivan, R E Ferner, Christine M. Stork, Brent Morgan and Timothy J. Wiegand and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and Disability and Rehabilitation.

In The Last Decade

Michael Holland

47 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Holland United Kingdom 17 183 121 84 80 76 49 785
Yongling Xiao United States 22 56 0.3× 85 0.7× 29 0.3× 91 1.1× 188 2.5× 46 1.2k
Lee A. Wanke United States 13 227 1.2× 41 0.3× 58 0.7× 58 0.7× 44 0.6× 21 1.0k
Richard L. Gorman United States 18 21 0.1× 212 1.8× 95 1.1× 84 1.1× 21 0.3× 40 1.2k
Sheila R. Weiss United States 14 33 0.2× 18 0.1× 34 0.4× 59 0.7× 35 0.5× 24 615
James P Sheppard United Kingdom 23 24 0.1× 56 0.5× 34 0.4× 70 0.9× 43 0.6× 102 1.5k
F Conso France 18 21 0.1× 131 1.1× 49 0.6× 291 3.6× 30 0.4× 76 1.1k
Mark T. Holdsworth United States 22 29 0.2× 38 0.3× 69 0.8× 100 1.3× 148 1.9× 61 1.4k
Jordan Tobin United States 7 82 0.4× 23 0.2× 40 0.5× 224 2.8× 71 0.9× 8 1.5k
Nidal Asaad Qatar 19 26 0.1× 98 0.8× 19 0.2× 76 0.9× 69 0.9× 115 1.3k
Julia Dixon United States 13 39 0.2× 336 2.8× 176 2.1× 31 0.4× 32 0.4× 51 1.2k

Countries citing papers authored by Michael Holland

Since Specialization
Citations

This map shows the geographic impact of Michael Holland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Holland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Holland more than expected).

Fields of papers citing papers by Michael Holland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Holland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Holland. The network helps show where Michael Holland may publish in the future.

Co-authorship network of co-authors of Michael Holland

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Holland. A scholar is included among the top collaborators of Michael Holland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Holland. Michael Holland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khair, Kate, et al.. (2024). Bleeding and quality of life in people with Glanzmann thrombasthenia—insights from the Glanzmann’s 360 study. Research and Practice in Thrombosis and Haemostasis. 8(7). 102586–102586. 1 indexed citations
2.
Nacca, Nicholas, et al.. (2024). Routine blood testing for "Forever Chemicals": implications of the 2022 NASEM PFAS report recommendations. SHILAP Revista de lepidopterología. 8(1).
3.
Fletcher, Simon, et al.. (2024). Barriers to gene therapy, understanding the concerns people with haemophilia have: an exigency sub-study. Orphanet Journal of Rare Diseases. 19(1). 59–59. 2 indexed citations
4.
Khair, Kate, et al.. (2023). Prevalence and perceptions of pain in people with haemophilia: A UK study. Haemophilia. 29(6). 1509–1518. 7 indexed citations
5.
Fletcher, Simon, et al.. (2023). Expectation and loss when gene therapy for haemophilia is not an option: An exigency sub‐study. Haemophilia. 29(3). 776–783. 3 indexed citations
6.
Fletcher, Simon, et al.. (2022). The experiences of people with haemophilia and their families of gene therapy in a clinical trial setting: regaining control, the Exigency study. Orphanet Journal of Rare Diseases. 17(1). 155–155. 26 indexed citations
7.
Chaplin, Steve, et al.. (2022). The lived experience of women with a bleeding disorder: A systematic review. Research and Practice in Thrombosis and Haemostasis. 6(1). e12652–e12652. 20 indexed citations
8.
Khair, Kate, et al.. (2021). “It's a way of life”: Results from the Perceptions of Pain in Haemophilia study. SHILAP Revista de lepidopterología. 8(1). 145–154. 2 indexed citations
9.
Holland, Michael, et al.. (2020). COVID-19 Personal Protective Equipment (PPE) for the emergency physician. Visual Journal of Emergency Medicine. 19. 100740–100740. 114 indexed citations
10.
Pollard, Debra, Kate Khair, & Michael Holland. (2020). Experience of switching to NovoEight: views of people with haemophilia. SHILAP Revista de lepidopterología. 7(1). 70–77. 1 indexed citations
11.
Mackensen, Sylvia von, Kaan Kavaklı, Anna Klukowska, et al.. (2019). The impact of psychosocial determinants on caregivers’ burden of children with haemophilia (results of the BBC study). Haemophilia. 25(3). 424–432. 16 indexed citations
12.
Holland, Michael, et al.. (2018). Transforming Transition: enhancing practice in haemophilia. 5(1). 111–121. 1 indexed citations
13.
Khair, Kate, Melanie Bladen, & Michael Holland. (2013). Physical function and quality of life in adolescents with haemophilia (SO-FIT study). 1(2). 11–14. 6 indexed citations
14.
Johns, Susan, et al.. (2013). Potential for development of haemophilia link nurse role within UK hospitals. Haemophilia. 19(4). 578–582. 5 indexed citations
15.
Sullivan, Ross, Jamie L. Nelsen, Srinivas Duggineni, & Michael Holland. (2012). Management of methylergonovine induced respiratory depression in a newborn with naloxone. Clinical Toxicology. 51(1). 47–49. 3 indexed citations
16.
Khair, Kate, Michael Holland, & Sarah J. Carrington. (2011). Social networking for adolescents with severe haemophilia. Haemophilia. 18(3). e290–6. 16 indexed citations
17.
Holland, Michael, et al.. (2011). Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH). Forensic Science International. 212(1-3). 247–251. 31 indexed citations
18.
Davidson, A C, et al.. (2008). Prolonged benefit in post-polio syndrome from comprehensive rehabilitation: A pilot study. Disability and Rehabilitation. 31(4). 309–317. 26 indexed citations
19.
Phillips, Scott, et al.. (2008). Development of emergency response planning guidelines (ERPGs). Journal of Medical Toxicology. 4(2). 127–131. 12 indexed citations
20.
Marraffa, Jeanna M., Michael Holland, Christine M. Stork, Christopher D. Hoy, & Michael Hodgman. (2007). Diethylene Glycol: Widely Used Solvent Presents Serious Poisoning Potential. Journal of Emergency Medicine. 35(4). 401–406. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yongling Xiao Breakdown of academic impact, for papers by Lee A. Wanke Breakdown of academic impact, for papers by Richard L. Gorman Breakdown of academic impact, for papers by Sheila R. Weiss Breakdown of academic impact, for papers by James P Sheppard Breakdown of academic impact, for papers by F Conso Breakdown of academic impact, for papers by Mark T. Holdsworth Breakdown of academic impact, for papers by Jordan Tobin Breakdown of academic impact, for papers by Nidal Asaad Breakdown of academic impact, for papers by Julia Dixon
Rankless by CCL
2026